FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/04/107397 [Registered on: 02/04/2026] Trial Registered Prospectively
Last Modified On: 23/07/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparing the effect of different adjuvants to hyperbaric Bupivacaine in subarachnoid block in lower limb orthopedic suregeries 
Scientific Title of Study   A randomized controlled trial of comparing the effects of different adjuvants to hyperbaric Bupivacaine in subarachnoid block in patients undergoing lower limb orthopedic surgeries 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shaik Nagoor Vali 
Designation  Junior Resident Anaesthesiology 
Affiliation  7 AIR FORCE HOSPITAL 
Address  Department of Anaesthesia, 7 Air Force Hospital,Gale road, Kanpur Cantt
Department of Anaesthesia, 7 Air Force Hospital,Gale road, Kanpur Cantt
Kanpur Nagar
UTTAR PRADESH
208001
India 
Phone  8008212019  
Fax    
Email  nagurvali7@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Wg Cdr Dr Bhaskar Das 
Designation  Consultant Anaesthesia 
Affiliation  7 AIR FORCE HOSPITAL 
Address  Department of Anaesthesia, 7 Air Force Hospital,Gale road, Kanpur Cantt
Department of Anaesthesia, 7 Air Force Hospital,Gale road, Kanpur Cantt
Kanpur Nagar
UTTAR PRADESH
208001
India 
Phone  7507088990  
Fax    
Email  drbhaskar23@gmail.com   
 
Details of Contact Person
Public Query
 
Name  Wg Cdr Dr Bhaskar Das 
Designation  Consultant Anaesthesia 
Affiliation  7 AIR FORCE HOSPITAL 
Address  Department of Anaesthesia, 7 Air Force Hospital,Gale road, Kanpur Cantt
Department of Anaesthesia, 7 Air Force Hospital,Gale road, Kanpur Cantt
Kanpur Nagar
UTTAR PRADESH
208001
India 
Phone  7507088990  
Fax    
Email  drbhaskar23@gmail.com   
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Air Force Hospital 
Address  Gale road, Cantonment Kanpur uttar pradesh, India 208004 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR SHAIK NAGOOR VALI  7 AIR FORCE HOSPITAL  Department of Anaesthesia, OT complex, Gale road, cantonment kanpur
Kanpur Nagar
UTTAR PRADESH 
8008212019

nagurvali7@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
7 AIR FORCE HOSPITAL  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M959||Acquired deformity of musculoskeletal system, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Adjuvants to hyperbaric Bupivacaine  One time addition of Dexmedetomidine to hyperbaric Bupivacaine in subarachnoid block. Effects monitored for 24 hours post spinal anaesthesia. 
Intervention  Adjuvants to hyperbaric Bupivacaine  One time addition of fentanyl to hyperbaric Bupivaccaine in subarachanoid block. Effects monitored for 24 hours post spinal anaesthesia. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Age more than 18 yrs 
 
ExclusionCriteria 
Details  Infection at the site of injection

Coagulopathy or anticoagulation

Congenital anomalies of the lower spine

Any preexisting neuropathy

History of allergy to local anaesthetics 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
Duration of Postoperative analgesia, block characteristics  Outcome assessed at every 3 mins interval for first 15 mins followed by every 15 mins till completion of surgery. Hourly till regression of block in post op period. 
 
Secondary Outcome  
Outcome  TimePoints 
Side effects  Side effects assessed at every 3 mins interval for first 15 mins followed by every 15 mins till completion of surgery. Hourly till regression of block in post op period. 
 
Target Sample Size   Total Sample Size="138"
Sample Size from India="138" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   06/04/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Based on current evidence, dexmedetomidine 5 µg as an intrathecal adjuvant to 0.5 hyperbaric bupivacaine offers several advantages

Faster onset of both sensory and motor blockade

Prolonged block duration and postoperative analgesia
Better hemodynamic stability
Minimal side effects compared to opioids like fentanyl or nalbuphine

It is a superior and safe adjuvant that enhances the quality and duration of spinal anesthesia in lower abdominal and lower limb surgeries
 
Close